WO2004045369A3 - Nuclear receptor-based diagnostic, therapeutic, and screening methods - Google Patents
Nuclear receptor-based diagnostic, therapeutic, and screening methods Download PDFInfo
- Publication number
- WO2004045369A3 WO2004045369A3 PCT/US2003/036229 US0336229W WO2004045369A3 WO 2004045369 A3 WO2004045369 A3 WO 2004045369A3 US 0336229 W US0336229 W US 0336229W WO 2004045369 A3 WO2004045369 A3 WO 2004045369A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nuclear receptor
- polynucleotides
- methods
- polypeptides
- therapeutic
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003295500A AU2003295500A1 (en) | 2002-11-14 | 2003-11-12 | Nuclear receptor-based diagnostic, therapeutic, and screening methods |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42630502P | 2002-11-14 | 2002-11-14 | |
US60/426,305 | 2002-11-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004045369A2 WO2004045369A2 (en) | 2004-06-03 |
WO2004045369A3 true WO2004045369A3 (en) | 2007-03-01 |
Family
ID=32326328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/036229 WO2004045369A2 (en) | 2002-11-14 | 2003-11-12 | Nuclear receptor-based diagnostic, therapeutic, and screening methods |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003295500A1 (en) |
WO (1) | WO2004045369A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005075990A2 (en) * | 2004-02-07 | 2005-08-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a2 (nr4a2) |
WO2005075983A2 (en) * | 2004-02-07 | 2005-08-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a3 (nr4a3) |
WO2005085865A2 (en) * | 2004-03-09 | 2005-09-15 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with thyroid hormone receptor beta (thrb) |
WO2006005460A2 (en) * | 2004-07-15 | 2006-01-19 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 2, group e, member 1 (nr2e1) |
US9484123B2 (en) | 2011-09-16 | 2016-11-01 | Prc-Desoto International, Inc. | Conductive sealant compositions |
US10865446B2 (en) | 2012-11-02 | 2020-12-15 | The Johns Hopkins University | DNA methylation biomarkers of post-partum depression risk |
WO2014134627A1 (en) * | 2013-03-01 | 2014-09-04 | The Schepens Eye Research Institute, Inc. | Methods for modulating development and function of photoreceptors cells |
RU2716479C1 (en) * | 2018-09-13 | 2020-03-11 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" | Method for prediction of response to cardiac resynchronising therapy in patients with chronic heart failure |
RU2747679C1 (en) * | 2020-07-09 | 2021-05-12 | федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии" Министерства здравоохранения Российской Федерации | Method for predicting clinical course of highly differentiated neuroendocrine pancreatic tumors |
CN112725438B (en) * | 2021-02-05 | 2023-08-22 | 深圳市宝安区妇幼保健院 | Endometrial polyp methylation marker combination, detection kit and application |
CN116539902A (en) * | 2023-07-05 | 2023-08-04 | 中国医学科学院北京协和医院 | Application of differential lipid molecules as lipid markers and kit |
CN116539901A (en) * | 2023-07-06 | 2023-08-04 | 中国医学科学院北京协和医院 | Application of differential metabolite as diagnostic marker and kit |
-
2003
- 2003-11-12 WO PCT/US2003/036229 patent/WO2004045369A2/en not_active Application Discontinuation
- 2003-11-12 AU AU2003295500A patent/AU2003295500A1/en not_active Abandoned
Non-Patent Citations (2)
Title |
---|
FERNANDEZ-GUASTI A. ET AL.: "Sex Differences in the Distribution of Androgen Receptors in the Human Hypothalamus", THE JOURNAL OF COMPARATIVE NEUROLOGY, vol. 425, 2000, pages 422 - 435, XP003008292 * |
HAIDER N. ET AL.: "Mutation of a Nuclear Receptor Gene, NR2E3, Causes Enhanced S Cone Syndrome, a Disorder of Retinal Cell Fate", NATURE GENETICS, vol. 24, February 2000 (2000-02-01), pages 127 - 131, XP002203635 * |
Also Published As
Publication number | Publication date |
---|---|
WO2004045369A2 (en) | 2004-06-03 |
AU2003295500A8 (en) | 2004-06-15 |
AU2003295500A1 (en) | 2004-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004045369A3 (en) | Nuclear receptor-based diagnostic, therapeutic, and screening methods | |
WO2008105797A3 (en) | Polynucleotides encoding novel pcsk9 variants | |
WO2005026317A3 (en) | Polynucleotides encoding novel variants of the trp channel family member, ltrpc3 | |
ATE253111T1 (en) | NUCLEIC ACID SEQUENCES ENCODING THE CAPSAICIN RECEPTOR AND POLYPEPTIDES SIMILAR TO THE CAPSAICIN RECEPTOR AND USE THEREOF | |
JPWO2002044362A1 (en) | Diabetes treatment screening method | |
WO2005001061A3 (en) | Polynucleotides encoding novel adiponectin receptor variants | |
WO2004083388A3 (en) | Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74 | |
WO2004039940A3 (en) | Polynucleotide encoding novel human g-protein coupled receptors, and splice variants thereof | |
WO2003046147A3 (en) | Novel human g-protein coupled receptor, hgprbmy31, and variants and methods of use thereof | |
WO2002083856A3 (en) | Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof | |
EP1741792A4 (en) | Novel ligand of g-protein-conjugated receptor protein and use thereof | |
WO2001007612A3 (en) | Receptors and associated proteins | |
WO2000056405A3 (en) | Human tumor necrosis factor receptor-like 2 | |
WO2004087622A3 (en) | Gpr54 receptor agonist and antagonist useful for the treatmentt of gonadotropin related diseases | |
WO2006116688A3 (en) | Mif agonists and antagonists and therapeutic uses thereof | |
WO2003083078A3 (en) | Novel human cell surface protein with immunoglobulin folds, bgs-19 | |
WO2003027231A3 (en) | Polynucleotide encoding adapter protein, pmn29 | |
WO2005052123A3 (en) | Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof | |
WO2004094621A3 (en) | Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof | |
WO2007008604A3 (en) | Single nucleotide polymorphisms associated with dose-dependent edema and methods of use thereof | |
WO2004005487A3 (en) | Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42 | |
WO2004090097A3 (en) | Polynucleotide encoding a novel human p2x7 splice variant, hbmyp2x7v | |
WO2004015082A3 (en) | Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same | |
WO2002072755A3 (en) | Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy27 | |
WO2002063004A3 (en) | G-protein coupled receptors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |